MINERVA SURGICAL, IN
UTRS
 Delayed - 08/18 04:00:00 pm |
|
| 1.99USD | +1.53% |
Valuation
| Fiscal Period: December | 2021 | 2022 | ||||
| Capitalization1 | 148 | 57,4 | ||||
| Enterprise Value (EV)1 | 139 | 69,5 | ||||
| P/E ratio | -1,68x | -1,75x | ||||
| Yield | - | - | ||||
| Capitalization / Revenue | 2,84x | 1,12x | ||||
| EV / Revenue | 2,68x | 1,36x | ||||
| EV / EBITDA | -4,79x | -2,80x | ||||
| Price to Book | - | - | ||||
| Nbr of stocks (in thousands) | 28 816 | 28 860 | ||||
| Reference price (USD) | 5,14 | 1,99 | ||||
| Announcement Date | 03/08/2022 | - | ||||
|
||||||
1 USD in Million |
Estimates
|
|||||
Previous period
Income Statement Evolution
Annual Income Statement Data
| Fiscal Period: December | 2021 | 2022 | |||||
| Net sales1 | 52,1 | 51,1 | |||||
| EBITDA1 | -29,1 | -24,8 | |||||
| Operating profit (EBIT)1 | -29,1 | -30,2 | |||||
| Operating Margin | -55,9% | -59,1% | |||||
| Pre-Tax Profit (EBT)1 | -21,5 | -32,6 | |||||
| Net income1 | -21,5 | -32,6 | |||||
| Net margin | -41,2% | -63,9% | |||||
| EPS2 | -3,06 | -1,14 | |||||
| Dividend per Share | - | - | |||||
| Announcement Date | 03/08/2022 | - | |||||
|
|||||||
1 USD in Million 2 USD |
Estimates
|
||||||
Finances - Leverage
| Fiscal Period: December | 2021 | 2022 | |||||
| Net Debt1 | - | 12,1 | |||||
| Net Cash position1 | 8,62 | - | |||||
| Leverage (Debt / EBITDA) | 0,30x | -0,49x | |||||
| Free Cash Flow1 | -23,0 | 2,00 | |||||
| ROE (Net Profit / Equities) | - | - | |||||
| Shareholders' equity1 | - | - | |||||
| ROA (Net Profit / Asset) | -39,1% | -30,9% | |||||
| Assets1 | 54,9 | 106 | |||||
| Book Value Per Share | - | - | |||||
| Cash Flow per Share | - | - | |||||
| Capex | 0,58 | - | |||||
| Capex / Sales | 1,12% | - | |||||
| Announcement Date | 03/08/2022 | - | |||||
|
|||||||
1 USD in Million |
Estimates
|
||||||
Financial Ratios
|
EPS & Dividend
